An analysis on the state of pharmaceutical drug pricing revealed that, despite rebates, consumers' out-of-pocket costs have grown faster than their insurers' prices. Today, an analysis published in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback